Lori Holle

A matrix metalloproteinase 2 cleavable melittin/avidin conjugate specifically targets tumor cells in vitro and in vivo

Lori Holle, Wendy Song, Eric Holle et al. · International Journal of Oncology · 2003 · 79 citations

Immunology, Tumor Cells, Matrix Metalloproteinase 2 +16

In vivo studies of the anti-tumor effects of a human prolactin antagonist, hPRL-G129R

Ningbo Chen, Lori Holle, W. Li et al. · International Journal of Oncology · 2002 · 57 citations

A novel design of targeted endocrine and cytokine therapy for breast cancer.

Guorong Zhang, Wěi Li, Lori Holle et al. · PubMed · 2002 · 39 citations

Breast Oncology, Immunology, Immunologic Mechanism +18

Bcl-2 targeting siRNA expressed by a T7 vector system inhibits human tumor cell growth in vitro

Lori Holle, Labri Hicks, Wendy Song et al. · International Journal of Oncology · 2004 · 23 citations

T7 Vector System, Breast Oncology, Bcl-2 Sirna +13

Efficient translocation and apoptosis induction by adenovirus encoded VP22-p53 fusion protein in human tumor cells in vitro.

Illa Roy, Lori Holle, Wendy Song et al. · PubMed · 2003 · 20 citations